FibroBiologics, Inc. Common Stock (FBLG) financial statements and ratios from SEC XBRL: revenue $247000.00 (TTM), net margin -7549.0%, revenue growth -1.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $247000.00 |
| Net Margin | -7549.0% |
| Revenue Growth (YoY) | -1.6% |
| EPS Growth (YoY) | 23.5% |
| FCF Growth (YoY) | 37.8% |
| Price / Book | 0.90 |
| Price / Sales | 32.61 |
| FCF Yield | -715.6% |
| Altman Z-Score | -5.65 (distress) |
| Sector P/E (Healthcare) | 21.7 |
FBLG overview · FBLG earnings · FBLG KPIs · FBLG investor relations · FBLG ownership · FBLG peers · FBLG filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.